Literature DB >> 22533079

Potential of the bush mint, Hyptis suaveolens essential oil for personal protection against mosquito biting.

Ayaba Z Abagli1, Thiery B C Alavo, Félicien Avlessi, Mansourou Moudachirou.   

Abstract

We studied the potential of the essential oil extract from the bush mint, Hyptis suaveolens, for use against mosquito biting under both laboratory and field conditions. In the laboratory, the repellency of various concentrations (1-6%) of the essential oil was assessed against Anopheles gambiae, based on a 15-min landing and biting on treated forearms of volunteers. In the laboratory, the percentage of mosquitoes landing on the forearm was 42, 33, 23, 23, 9, and 2 for 1%, 2%, 3%, 4%, 5%, and 6% essential oil concentration, respectively; and 92 and 91 for the solvent (isopropanol) and untreated control, respectively. The percentage of mosquitoes taking a blood meal was 22, 12, 13, 12, 5, and 3 for 1%, 2%, 3%, 4%, 5%, and 6% essential oil, respectively; and 52 and 51 for the solvent and control, respectively. In the field, the 6% essential oil repelled all mosquitoes immediately postapplication; this activity declined to 75% after 5 h. The repellent action of the 8% essential oil concentration was higher, 97% after 5 h. Based on these data, the essential oil of H. suaveolens appears to be a good candidate for use in the integrated management of mosquito vectors of disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22533079     DOI: 10.2987/11-6181.1

Source DB:  PubMed          Journal:  J Am Mosq Control Assoc        ISSN: 8756-971X            Impact factor:   0.917


  1 in total

Review 1.  Traditional Uses, Phytochemistry, and Bioactivities of Mesosphaerum suaveolens (L.) Kuntze.

Authors:  José Weverton Almeida-Bezerra; Felicidade Caroline Rodrigues; José Jailson Lima Bezerra; Anderson Angel Vieira Pinheiro; Saulo Almeida de Menezes; Aline Belém Tavares; Adrielle Rodrigues Costa; Priscilla Augusta de Sousa Fernandes; Viviane Bezerra da Silva; José Galberto Martins da Costa; Rafael Pereira da Cruz; Maria Flaviana Bezerra Morais-Braga; Henrique Douglas Melo Coutinho; Edward Teixeira de Albergaria; Marcos Vinicius Meiado; Abolghasem Siyadatpanah; Bonglee Kim; Antônio Fernando Morais de Oliveira
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-10       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.